Reported Tuberculosis in the United States, 2019

Return to Main Menu

Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2019

Table 45. Culture-Positive Tuberculosis Cases and Percentages with Drug-Susceptibility Results, by Resistance to Isoniazid or Multidrug Resistance: Reporting Areas, 2018
Reporting Area Total Culture Positive Cases Cases with Initial Drug-Susceptibility Testing Performed1 Resistance2
Isoniazid1 Isoniazid and Rifampin1
No. (%) No. (%) No. (%)
United States 7,097 6,660 (93.8) 631 (9.5) 90 (1.4)
Alabama 75 67 (89.3) 4 (6.0) 1 (1.5)
Alaska 43 42 (97.7) 4 (9.5) 0 (0.0)
Arizona 132 131 (99.2) 11 (8.4) 0 (0.0)
Arkansas 50 50 (100.0) 1 (2.0) 0 (0.0)
California 1,759 1,709 (97.2) 178 (10.4) 17 (1.0)
Colorado 45 45 (100.0) 6 (13.3) 0 (0.0)
Connecticut 57 56 (98.2) 4 (7.1) 1 (1.8)
Delaware 15 13 (86.7) 1 (7.7) 0 (0.0)
District of Columbia 20 20 (100.0) 2 (10.0) 0 (0.0)
Florida 446 434 (97.3) 29 (6.7) 7 (1.6)
Georgia 206 200 (97.1) 21 (10.5) 1 (0.5)
Hawaii 81 80 (98.8) 10 (12.5) 0 (0.0)
Idaho 6 6 (100.0) 1 (16.7) 0 (0.0)
Illinois 217 195 (89.9) 15 (7.7) 2 (1.0)
Indiana 74 73 (98.6) 9 (12.3) 1 (1.4)
Iowa 39 39 (100.0) 3 (7.7) 0 (0.0)
Kansas 37 4 (10.8) 0 (0.0) 0 (0.0)
Kentucky 41 40 (97.6) 2 (5.0) 1 (2.5)
Louisiana 74 68 (91.9) 8 (11.8) 0 (0.0)
Maine 13 12 (92.3) 1 (8.3) 0 (0.0)
Maryland 169 161 (95.3) 13 (8.1) 2 (1.2)
Massachusetts 142 140 (98.6) 17 (12.1) 2 (1.4)
Michigan 92 91 (98.9) 6 (6.6) 1 (1.1)
Minnesota 127 123 (96.9) 13 (10.6) 6 (4.9)
Mississippi 42 42 (100.0) 4 (9.5) 0 (0.0)
Missouri 50 2 (4.0) 0 (0.0) 0 (0.0)
Montana 2 2 (100.0) 0 (0.0) 0 (0.0)
Nebraska 13 11 (84.6) 1 (9.1) 1 (9.1)
Nevada 46 45 (97.8) 5 (11.1) 0 (0.0)
New Hampshire 6 6 (100.0) 1 (16.7) 0 (0.0)
New Jersey 251 247 (98.4) 23 (9.3) 4 (1.6)
New Mexico 29 29 (100.0) 2 (6.9) 0 (0.0)
New York State3 149 128 (85.9) 16 (12.5) 1 (0.8)
New York City 460 445 (96.7) 50 (11.2) 12 (2.7)
North Carolina 163 160 (98.2) 9 (5.6) 2 (1.3)
North Dakota 15 11 (73.3) 0 (0.0) 0 (0.0)
Ohio 110 110 (100.0) 6 (5.5) 2 (1.8)
Oklahoma 57 57 (100.0) 7 (12.3) 1 (1.8)
Oregon 49 49 (100.0) 3 (6.1) 1 (2.0)
Pennsylvania 167 160 (95.8) 11 (6.9) 1 (0.6)
Rhode Island 9 8 (88.9) 1 (12.5) 0 (0.0)
South Carolina 68 67 (98.5) 3 (4.5) 1 (1.5)
South Dakota 15 15 (100.0) 1 (6.7) 0 (0.0)
Tennessee 96 93 (96.9) 3 (3.2) 1 (1.1)
Texas 927 764 (82.4) 84 (11.0) 11 (1.4)
Utah 18 18 (100.0) 2 (11.1) 0 (0.0)
Vermont 4 4 (100.0) 0 (0.0) 0 (0.0)
Virginia 158 158 (100.0) 12 (7.6) 2 (1.3)
Washington 180 177 (98.3) 22 (12.4) 8 (4.5)
West Virginia 5 5 (100.0) 0 (0.0) 0 (0.0)
Wisconsin 47 47 (100.0) 6 (12.8) 0 (0.0)
Wyoming 1 1 (100.0) 0 (0.0) 0 (0.0)
American Samoa4 1 1 (100.0) 0 (0.0) 0 (0.0)
Fed. States of Micronesia4 34 34 (100.0) 1 (2.9) 0 (0.0)
Guam4 53 51 (96.2) 7 (13.7) 2 (3.9)
Marshall Islands4 41 38 (92.7) 0 (0.0) 0 (0.0)
N. Mariana Islands4 25 25 (100.0) 3 (12.0) 0 (0.0)
Puerto Rico4 32 32 (100.0) 10 (31.3) 3 (9.4)
Republic of Palau4 5 5 (100.0) 0 (0.0) 0 (0.0)
U.S. Virgin Islands4 0 0 0 0

1Patients tested to at least isoniazid and rifampin.
2Isolates may be resistant to other drugs.
3Excludes New York City.
4Not included in U.S. totals.
Ellipses (…) indicate that the percentage cannot be calculated, and the denominator is 0.
Zero % (0.0) denotes <0.05%.

Table Printing Tips  pdf icon[PDF – 934 KB]